Sujeong Kim, Ph.D.

Principal Scientist

Dr. Sujeong Kim is a principal scientist and immunologist at Centivax. Most of her research career has been focused on antibody engineering. She identified several potent anti-MERS-CoV neutralizing antibodies and successfully engineered the antibody to resist the stress conveyed during the nebulization. She also identified potent bispecific antibodies and antibody-drug conjugate to treat autoimmune diseases and are under preclinical development stage. She earned her PhD and Postdoc training from the Seoul National University College of Medicine, Seoul, South Korea.